David S. Silberstein's Insider Trades & SAST Disclosures

David S. Silberstein's most recent trade in Lantern Pharma Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lantern Pharma Inc
David S. Silberstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2024 5,000 5,000 - - Stock Option (Right to Buy)
Lantern Pharma Inc
David S. Silberstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2024 5,000 5,000 - - Stock Option (Right to Buy)
Lantern Pharma Inc
David S. Silberstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 3,200 3,200 - - Stock Option (Right to Buy)
Lantern Pharma Inc
David S. Silberstein Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2020 9,135 9,135 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades